- Home
- PULM vs OPAD Comparison
PULM vs OPAD Comparison
Compare PULM & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- OPAD
- Stock Information
- Founded
- PULM 2003
- OPAD 2015
- Country
- PULM United States
- OPAD United States
- Employees
- PULM N/A
- OPAD N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- OPAD Real Estate
- Sector
- PULM Health Care
- OPAD Finance
- Exchange
- PULM Nasdaq
- OPAD Nasdaq
- Market Cap
- PULM 33.2M
- OPAD 25.3M
- IPO Year
- PULM N/A
- OPAD N/A
- Fundamental
- Price
- PULM $6.21
- OPAD $1.52
- Analyst Decision
- PULM
- OPAD Hold
- Analyst Count
- PULM 0
- OPAD 5
- Target Price
- PULM N/A
- OPAD $2.38
- AVG Volume (30 Days)
- PULM 58.4K
- OPAD 148.4K
- Earning Date
- PULM 08-12-2025
- OPAD 08-04-2025
- Dividend Yield
- PULM N/A
- OPAD N/A
- EPS Growth
- PULM N/A
- OPAD N/A
- EPS
- PULM N/A
- OPAD N/A
- Revenue
- PULM $1,921,000.00
- OPAD $794,159,000.00
- Revenue This Year
- PULM N/A
- OPAD N/A
- Revenue Next Year
- PULM $134.88
- OPAD $40.79
- P/E Ratio
- PULM N/A
- OPAD N/A
- Revenue Growth
- PULM N/A
- OPAD N/A
- 52 Week Low
- PULM $1.78
- OPAD $0.91
- 52 Week High
- PULM $10.40
- OPAD $5.13
- Technical
- Relative Strength Index (RSI)
- PULM 41.72
- OPAD 64.86
- Support Level
- PULM $6.28
- OPAD $1.31
- Resistance Level
- PULM $6.83
- OPAD $1.52
- Average True Range (ATR)
- PULM 0.44
- OPAD 0.14
- MACD
- PULM -0.05
- OPAD 0.04
- Stochastic Oscillator
- PULM 13.89
- OPAD 69.32
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.